Waystar Signals AI-Driven Growth Despite Near-Term Bumps

Waystar Holding Corp. ((WAY)) has held its Q1 earnings call. Read on for the main highlights of the call.

Waystar Holding Corp.’s latest earnings call struck an upbeat tone, as management balanced robust top-line growth and rising profitability with a candid acknowledgment of near-term pressure in patient payment volumes. Executives stressed that AI-driven momentum, high customer retention, and a record pipeline outweigh seasonal and mix-related headwinds that may dampen growth over the next couple of quarters.

Strong Revenue Growth

Waystar opened 2026 with a solid top line, reporting Q1 revenue of $314 million, up 22% year over year and 11% organically. Management credited disciplined execution and broader adoption across its platform, positioning the company as a growing backbone for healthcare revenue cycle operations.

Subscription Momentum

Subscription revenue remained the standout, climbing 38% year over year to $172 million and now accounting for 55% of total revenue. The subscription business also expanded organically at 14%, underscoring a steady shift toward more recurring, predictable revenue streams with modest 3% sequential growth.

Robust Profitability and Cash Generation

Profitability continued to strengthen, with adjusted EBITDA rising 26% year over year to $135 million and margins reaching 43%. Unlevered free cash flow reached $90 million, translating to a healthy 67% conversion of adjusted EBITDA and signaling ample capacity to fund growth while reducing balance-sheet risk.

High Customer Retention and Expansion

Customer dynamics remained favorable, with net revenue retention of about 111%, slightly above the company’s historical range. Waystar added 42 new clients generating more than $100,000 in trailing 12-month revenue, bringing that cohort to 1,433 customers, roughly 15% higher than a year ago.

AI Traction and Product Innovation

AI continued to emerge as a central growth engine, with AI-powered capabilities driving roughly 40% of new bookings in the quarter. About half of Waystar’s solutions now incorporate AI and nearly 40% of revenue flows through AI-embedded workflows, supported by new offerings in prebill analytics, recoupment, and patient financial tools.

Compelling Early AI Outcomes

Management highlighted tangible benefits from these AI tools, including a prebill anomaly solution estimated to deliver about $3 million in net revenue per 10,000 discharges. Another recoupment product cut reconciliation time by more than 80% and surfaced $32 million of revenue risk for an early client, while the Altitude suite is expected to lift collections roughly 50% in targeted use cases.

Scale and Network Advantage

The company emphasized the strategic value of its scale, processing over 7.5 billion transactions annually and connecting more than 1 million providers with major payers. With more than 100,000 live integrations and touchpoints with about 60% of the U.S. patient population, Waystar argued its data rails create powerful network effects and learning advantages.

Strong Sales Momentum and Pipeline

Sales metrics pointed to continued momentum, with bookings running ahead of internal expectations and a double-digit number of contracts exceeding $1 million in annual recurring revenue. Management also cited the largest qualified pipeline in company history, coupled with higher win rates and larger deal sizes across customer segments.

Patient Payment Volume Headwinds

The main weak spot appeared in patient payment solutions, which make up roughly a quarter of revenue and faced softer volumes in Q1. While volume-based revenue still grew 7% year over year to $139 million, the company saw headwinds from faster shifts to digital statements, adverse weather, and changing patient utilization and coverage patterns.

Near-Term Seasonality and Q2 Moderation

These volume dynamics are prompting a tempered near-term outlook, with the company now expecting Q2 sequential revenue growth to be flat to up 1%, versus a prior 1–3% ramp. Management still sees Q3 growth improving to 1–3%, but acknowledged that tighter seasonality and moderation from recent trends will likely keep quarterly gains more muted.

Implementation Backlog and Longer Revenue Lead Times

Waystar’s success in closing larger, multi-solution deals is also stretching the timeline for revenue conversion, with typical lead times now 6–18 months. An elevated implementation backlog reflects these bigger contracts, including many over $1 million in ARR, which strengthen long-term visibility but defer near-term revenue recognition.

High Gross Debt Level and Revenue Mix Risks

On the balance sheet, the company ended the quarter with $1.5 billion of gross debt and $159 million of cash, bringing net leverage down to 2.7 times from 3.0 times. While growth is tilting toward higher-margin provider solutions, slower patient payment growth and the shift from print to digital can temporarily depress reported volume-based revenue even as margins remain intact.

Forward-Looking Guidance and Outlook

Waystar reaffirmed its full-year 2026 outlook, targeting revenue of $1.274–$1.294 billion and adjusted EBITDA of $530–$540 million, implying roughly 17% top-line growth and 10% normalized organic expansion. The company plans to keep net leverage at or below 3.0 times, leaning on strong Q1 results, robust bookings, and AI-driven demand to offset near-term seasonal and mix-related pressures.

Waystar’s earnings call painted the picture of a company navigating short-term volume bumps while leaning into scale, AI, and subscription growth to drive long-term value. For investors, the combination of high-margin expansion, resilient cash generation, and a record pipeline suggests that near-term moderation may be a pause rather than a pivot in the company’s growth story.